Pacemaker, Artificial

2

Review clinical trials related to Pacemaker, Artificial. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Slew Rate As a Predictor for Optimal Lead Fixation

The goal of this observational study is to identify the most reliable electrical parameter measured at the time of implantation that can predict optimal lead fixation and long-term lead performance in patients undergoing transvenous pacemaker or implantable cardioverter-defibrillator (ICD) implant. The main questions it aims to answer are: * Is there a correlation between the slew rate measured at the time of lead implantation and the sensing measured at the 12-month follow-up? * Is there a correlation between all electrical parameters recorded at implantation (including slew rate, current of injury, acute sensing, acute impedance, and acute pacing threshold) and the electrical parameters assessed at 12 months post-implantation (specifically chronic sensing, chronic impedance, and chronic pacing threshold)? Participants will undergo regular follow-up evaluations, with device interrogation visits scheduled at 1 and 12 months post-implantation as part of routine clinical care.

Participants needed: 516
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Paolo Pastori, MDUpdated: Feb 24, 2025Locations: 1Duration: 12 Months
Eligibility criteria

Implantation of a transvenous pacemaker with active lead fixation. [+1]

Pregnancy. [+4]

Status: Recruiting

Prospective Köln Bonn Registry for the Extraction of Pacmaker and ICD Leads

The KOBES registry is an all-comers prospective clinical registry of the cooperative Köln Bonn lead extraction center. All patients undergoing complex lead extraction procedures (i.e. indwelling leads \> 6months) in the hybrid operating room with cardiothoracic standby will be included in the registry. Preoperative, intraoperative/procedural and postoperative parameters will be recorded. All patients will be asked to provide written informed consent. Data will be pseudonomyzed and entered into a data sheet. Data will be monitored by a board and evaluated independently.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Evangelic Hospital Kalk CologneUpdated: Sep 19, 2024Locations: 1Duration: 1 Year
Eligibility criteria

All patients with a standard indication for lead extraction according to the HRS...

None